1. Comparison of SGLT1, SGLT2, and dual inhibitor biological activity in treating type 2 diabetes mellitus;Azizogli;Adv. Ther.,2023
2. Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives;Cefalo;Cardiovasc. Diabetol.,2019
3. Sugar binding residue affects apparent Na+ affinity and transport stoichiometry in mouse sodium/glucose cotransporter type 3B;D\’\iez-Sampedro, A., Barcelona, S;J. Biol. Chem.,2011
4. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules;Daina;Sci. Rep.,2017
5. Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium–glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020);Dashora;Diabet. Med.,2020